Matches in SemOpenAlex for { <https://semopenalex.org/work/W93752642> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W93752642 endingPage "607" @default.
- W93752642 startingPage "596" @default.
- W93752642 abstract "To summarize for pharmacists the Adult Treatment Panel III (ATP III), recently issued guidelines for managing hypercholesterolemia, from the National Cholesterol Education Program (NCEP). Executive summary of ATP III, and other pertinent literature as determined by the author. Not applicable. By the author. Like previous guidelines issued by NCEP, ATP III focuses on lowering of low-density lipoprotein cholesterol (LDL-C) as a primary focus and using exercise, diet, and pharmacotherapy as a primary means of lowering patients’ coronary heart disease (CHD) risks. The new guidelines recognize LDL-C levels of less than 100 mg/dL as optimal for all patients, and increase attention on high triglyceride levels (above 200 mg/dL). ATP III places more emphasis on identifying patients at risk for CHD and CHD events (e.g., myocardial infarctions, revascularization procedures). To apply the recommendations of ATP III in pharmaceutical care practice, pharmacists should follow a six-step process: (1) Assess the patient’s lipid profile (full panel, not just total cholesterol); (2) assess and categorize the patient’s CHO risk (using a point system reflecting the levels of risk inherent in certain factors); (3) establish treatment goals and approaches (the greater the risk, the more aggressive the management); (4) initiate therapeutic lifestyle changes (including new recommendations for low intake of saturated fats and dietary cholesterol); (5) initiate LDL-C lowering drug therapy (often with combination therapy); and (6) consider other lipid factors (particularly hypertriglyceridemia and the metabolic syndrome). Most patients who begin lipid-lowering therapy stop it within 1 year, and only about one-third of patients reach treatment goals. The release of the ATP III guidelines provides pharmacists a great opportunity to enhance pharmaceutical care services directed specifically at patients with hyperlipidemia." @default.
- W93752642 created "2016-06-24" @default.
- W93752642 creator A5054320288 @default.
- W93752642 date "2001-07-01" @default.
- W93752642 modified "2023-09-27" @default.
- W93752642 title "New Guidelines for Managing Hypercholesterolemia" @default.
- W93752642 cites W2118310760 @default.
- W93752642 cites W2143465004 @default.
- W93752642 cites W4238251256 @default.
- W93752642 doi "https://doi.org/10.1016/s1086-5802(16)31284-0" @default.
- W93752642 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11486986" @default.
- W93752642 hasPublicationYear "2001" @default.
- W93752642 type Work @default.
- W93752642 sameAs 93752642 @default.
- W93752642 citedByCount "7" @default.
- W93752642 countsByYear W937526422013 @default.
- W93752642 countsByYear W937526422015 @default.
- W93752642 countsByYear W937526422022 @default.
- W93752642 crossrefType "journal-article" @default.
- W93752642 hasAuthorship W93752642A5054320288 @default.
- W93752642 hasConcept C126322002 @default.
- W93752642 hasConcept C177713679 @default.
- W93752642 hasConcept C2776919658 @default.
- W93752642 hasConcept C2778163477 @default.
- W93752642 hasConcept C2778402494 @default.
- W93752642 hasConcept C2778913445 @default.
- W93752642 hasConcept C2780578515 @default.
- W93752642 hasConcept C500440147 @default.
- W93752642 hasConcept C511355011 @default.
- W93752642 hasConcept C71924100 @default.
- W93752642 hasConceptScore W93752642C126322002 @default.
- W93752642 hasConceptScore W93752642C177713679 @default.
- W93752642 hasConceptScore W93752642C2776919658 @default.
- W93752642 hasConceptScore W93752642C2778163477 @default.
- W93752642 hasConceptScore W93752642C2778402494 @default.
- W93752642 hasConceptScore W93752642C2778913445 @default.
- W93752642 hasConceptScore W93752642C2780578515 @default.
- W93752642 hasConceptScore W93752642C500440147 @default.
- W93752642 hasConceptScore W93752642C511355011 @default.
- W93752642 hasConceptScore W93752642C71924100 @default.
- W93752642 hasIssue "4" @default.
- W93752642 hasLocation W937526421 @default.
- W93752642 hasLocation W937526422 @default.
- W93752642 hasOpenAccess W93752642 @default.
- W93752642 hasPrimaryLocation W937526421 @default.
- W93752642 hasRelatedWork W1977507094 @default.
- W93752642 hasRelatedWork W1994077120 @default.
- W93752642 hasRelatedWork W1995317287 @default.
- W93752642 hasRelatedWork W2005022918 @default.
- W93752642 hasRelatedWork W2005809346 @default.
- W93752642 hasRelatedWork W2047044978 @default.
- W93752642 hasRelatedWork W2048722271 @default.
- W93752642 hasRelatedWork W2083470316 @default.
- W93752642 hasRelatedWork W2085329541 @default.
- W93752642 hasRelatedWork W2391091442 @default.
- W93752642 hasVolume "41" @default.
- W93752642 isParatext "false" @default.
- W93752642 isRetracted "false" @default.
- W93752642 magId "93752642" @default.
- W93752642 workType "article" @default.